Quick10K

⚲

OWC Pharmaceutical Research

Filings

10-Q	2019-09-30	Filed 2019-11-13
10-Q	2019-06-30	Filed 2019-08-13
S-1	2019-05-31	Public Filing
10-Q	2019-03-31	Filed 2019-05-15
10-K	2018-12-31	Filed 2019-04-01
10-Q	2018-09-30	Filed 2018-11-08
10-Q	2018-06-30	Filed 2018-08-16
S-1	2018-06-14	Public Filing
10-Q	2018-03-31	Filed 2018-05-15
10-K	2017-12-31	Filed 2018-04-16
10-Q	2017-09-30	Filed 2017-11-14
10-Q	2017-06-30	Filed 2017-08-21
10-Q	2017-03-31	Filed 2017-05-18
10-K	2016-12-31	Filed 2017-04-17
10-Q	2016-09-30	Filed 2016-11-14
10-Q	2016-06-30	Filed 2016-08-29
10-Q	2016-03-31	Filed 2016-05-16
10-K	2015-12-31	Filed 2016-04-14
10-Q	2015-09-30	Filed 2015-11-13
10-Q	2015-06-30	Filed 2015-08-17
10-Q	2015-03-31	Filed 2015-05-15
10-K	2014-12-31	Filed 2015-04-01
10-Q	2014-09-30	Filed 2014-11-14
10-Q	2014-06-30	Filed 2014-07-29
10-Q	2014-03-31	Filed 2014-05-08
10-K	2013-12-31	Filed 2014-03-21
10-Q	2013-09-30	Filed 2013-11-07
10-Q	2013-06-30	Filed 2013-08-12
10-Q	2013-03-31	Filed 2013-05-14
10-K	2012-12-31	Filed 2013-04-15

Reports

8-K	2020-09-23
8-K	2020-09-14
8-K	2020-08-31
8-K	2020-06-25
8-K	2020-06-21
8-K	2020-03-30
8-K	2020-03-19
8-K	2020-03-12
8-K	2020-03-09
8-K	2019-12-20
8-K	2019-12-12
8-K	2019-11-13
8-K	2019-11-13
8-K	2019-10-22
8-K	2019-10-07
8-K	2019-09-16
8-K	2019-08-29
8-K	2019-07-24
8-K	2019-05-23
8-K	2019-05-06
8-K	2019-04-15
8-K	2019-04-04
8-K	2019-03-13
8-K	2019-02-22
8-K	2019-02-05
8-K	2019-02-01
8-K	2019-01-29
8-K	2018-12-31
8-K	2018-11-30
8-K	2018-11-30
8-K	2018-10-22
8-K	2018-08-21
8-K	2018-08-01
8-K	2018-06-28
8-K	2018-06-13
8-K	2018-04-30
8-K	2018-03-08
8-K	2018-03-05
8-K	2018-02-19

OWC Pharmaceutical Research Financials

OWCP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
1Life Healthcare (ONEM)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
20 20 Global (TWGL)
111 (YI)				0%	1,546,418	322,654	0	0	0	0	-853,740
1 800 Flowers Com (FLWS)	944,324	42%	13.3	6%	664,955	335,559	1,266,390	533,727	36,761	75,090	1,000,932
10x Genomics (TXG)	4,804,979	75%	-490.3	-2%	572,815	151,367	61,207	45,727	-9,603	-8,887	4,357,180
12 Retech (RETC)	0	32%	-0.1	-1,385%	1,118	20,421	625	199	-15,491	-14,800	966
1347 Property Insurance Holdings (PIH)	33,711	0%	0.4	-5%	164,088	108,405	18,194	0	-7,969	-8,017	-2,855
21st Century Oncology Holdings (RTSX)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	18,527	23,194	27,219	6,699	-2,862	-1,433	3,396
1895 Bancorp of Wisconsin (BCOW)	46,152,715		12,508.1	-0%	441,187	382,722	0	0	-44	3,689	46,142,359
1st Constitution Bancorp (FCCY)	164,504	0%	4.4	1%	1,342,565	1,204,038	490	0	13,787	32,503	143,748
024 Pharma (EEIG)


Balance Sheet ($'000)	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	4	17	8	2	9	847	1,389	1,469	1,166	799	532	357	266	162	90	472		1,380	1,113	971	692	4,649	4,219	3,464	2,800	1,840	1,465
Accounts Receivable
Inventory
PP&E							26	29	29	28	26	23			18	37	14	11	10	46	33	33	33	73	35	33	31
Assets	4	17	8	2	9	847	1,437	1,523	1,195	840	568	430	343	239	130	497	2,076	1,413	1,218	1,061	736	4,774	4,312	3,553	2,949	2,335	1,773
Accounts Payable							12	17	37	53	45				9	8	5	36	40	65	71	128	231	98	163	104	286
Long-Term Debt
Liabilities		74	102	128		49	81	60	40	56	47	108	315	351	237	396	448	176	208	270	234	6,424	6,768	10,767	10,251	1,750	1,467
Stockholders' Equity		-57	-94			798	1,356	1,463	1,154	785	521	323	28	-150	-107	101	1,627	1,237	1,010	791	502	-2,183	-3,791	-9,440	-10,242	-3,043	-4,008


Income Statement ($'000)	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50	0	0	0	0		100	0		100	0
Cost of Revenue
Gross Profit
R&D	0	0	0	0	0	0	0	160	99	77	97	-15	37	35	30	-244	34	216	94	-782	155	273	126		285	320	168
SG&A	59	149	14	9	472	-107	4,354	154	305	533	311	245	222	84	75	-2,387	1,401	1,558	1,106	-6,851	821	756	543		498	395	519
Tax	0	0	0		0	0	0		0	0	0				0
Net Income	-71	-170	-42	-35	-509		-4,354	-315	-405		-408	-233	-314	-80	-141	-1,658	-1,435	-445	-1,201	-1,477	-977	-2,990	-991		-1,000	7,707	-287


Cash Flow ($'000)	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating	-19	-49	-14	-9	-17	-22	-289	-274	-387	1,138	-1,795	-173	-172	-100	-126	-131	-191	-395	-274	-326	-371	-949	-427		-665	-955	-372
Cash Investing								-6	-2	-2	0	1				0	-1	0	-2	-6	-10	-10	-2		0	-2	0
Cash Financing	15	63	5	4	23	860	859	353	90	0	24	10	71	0	50	525	1,768	-273	10	189	105	4,918	0		0	0	0